Asked by: James Brokenshire (Conservative - Old Bexley and Sidcup)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answers of 28 January 2020 to Questions 7156 and 7157, how the next National Lung Cancer Audit will be published on 11 June 2020 when the contract for its provision expires on 31 March 2020.
Answered by Jo Churchill
Healthcare Quality Improvement Partnership (HQIP), as commissioner of the National Lung Cancer Audit (NLCA), has proposed a contract extension until after the publication date of the NLCA report on 11 June 2020. This extension has to be mutually agreed by the incumbent audit provider and HQIP are currently in discussions to confirm with them.
Asked by: James Brokenshire (Conservative - Old Bexley and Sidcup)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when the next annual national lung cancer audit will be published.
Answered by Jo Churchill
The current scheduled publication date for next National Lung Cancer Audit report is Thursday 11 June 2020.
Asked by: James Brokenshire (Conservative - Old Bexley and Sidcup)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, which body or organisation has been awarded the contract to prepare the next national lung cancer audit following the recent tender for this work through the Healthcare Quality Improvement Programme; and how many tenders were received for this work.
Answered by Jo Churchill
No decisions on awarding the contract to prepare the next National Lung Cancer Audit have currently been made. The current contract is due to expire on 31 March 2020.
Asked by: James Brokenshire (Conservative - Old Bexley and Sidcup)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, which clinical and health audits are carried out or maintained through (a) the Healthcare Quality Improvement Programme and (b) the National Clinical Audit and Patient Outcomes Programme.
Answered by Nadine Dorries
The National Clinical Audit and Patient Outcomes Programme (NCAPOP) is made up of a number of funding streams comprising over 30 topics and aim to mirror the priority areas set out in the NHS Long Term Plan. The National Quality Board (NQB) established an NQB NCAPOP Partners Group, with representation from NHS England and NHS Improvement, the Care Quality Commission, the National Institute for Health and Care Excellence (NICE) and Health Education England, amongst others, to ensure the NCAPOP portfolio continues to support the priorities of the wider National Health Service.
NCAPOP audits are commissioned by the Healthcare Quality Improvement Partnership (HQIP) which manages the programme on behalf of NHS England and NHS Improvement. In addition, NHS England and NHS Improvement have contractual accountability meetings to review the Key Performance indicators associated with the NCAPOP contract.
The following expenditure was provided for NCAPOP in recent years:
- 2016/17; £16.9 million;
- 2017/18; £16.9 million;
- 2018/19; £15.8 million; and
- 2019/20; £15.6 million.
Clinical audits delivered under the NCAPOP portfolio can be found at the following link:
https://www.hqip.org.uk/a-z-of-nca/#.XAlJvcK7KUk
NCAPOP outcome review of delivered work can be found at the following link:
https://www.hqip.org.uk/clinical-outcome-review-programmes/#.XiseTmC7JPY
Asked by: James Brokenshire (Conservative - Old Bexley and Sidcup)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what level of funding has been allocated to the work of (a) the National Clinical Audit and Patient Outcomes Programme and (b) the Healthcare Quality Improvement Programme in (i) financial year 2019-20 and (ii) each of the previous three financial years.
Answered by Nadine Dorries
The National Clinical Audit and Patient Outcomes Programme (NCAPOP) is made up of a number of funding streams comprising over 30 topics and aim to mirror the priority areas set out in the NHS Long Term Plan. The National Quality Board (NQB) established an NQB NCAPOP Partners Group, with representation from NHS England and NHS Improvement, the Care Quality Commission, the National Institute for Health and Care Excellence (NICE) and Health Education England, amongst others, to ensure the NCAPOP portfolio continues to support the priorities of the wider National Health Service.
NCAPOP audits are commissioned by the Healthcare Quality Improvement Partnership (HQIP) which manages the programme on behalf of NHS England and NHS Improvement. In addition, NHS England and NHS Improvement have contractual accountability meetings to review the Key Performance indicators associated with the NCAPOP contract.
The following expenditure was provided for NCAPOP in recent years:
- 2016/17; £16.9 million;
- 2017/18; £16.9 million;
- 2018/19; £15.8 million; and
- 2019/20; £15.6 million.
Clinical audits delivered under the NCAPOP portfolio can be found at the following link:
https://www.hqip.org.uk/a-z-of-nca/#.XAlJvcK7KUk
NCAPOP outcome review of delivered work can be found at the following link:
https://www.hqip.org.uk/clinical-outcome-review-programmes/#.XiseTmC7JPY
Asked by: James Brokenshire (Conservative - Old Bexley and Sidcup)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what oversight arrangements are in place to ensure that the work of the Healthcare Quality Improvement Programme is delivered effectively.
Answered by Nadine Dorries
The National Clinical Audit and Patient Outcomes Programme (NCAPOP) is made up of a number of funding streams comprising over 30 topics and aim to mirror the priority areas set out in the NHS Long Term Plan. The National Quality Board (NQB) established an NQB NCAPOP Partners Group, with representation from NHS England and NHS Improvement, the Care Quality Commission, the National Institute for Health and Care Excellence (NICE) and Health Education England, amongst others, to ensure the NCAPOP portfolio continues to support the priorities of the wider National Health Service.
NCAPOP audits are commissioned by the Healthcare Quality Improvement Partnership (HQIP) which manages the programme on behalf of NHS England and NHS Improvement. In addition, NHS England and NHS Improvement have contractual accountability meetings to review the Key Performance indicators associated with the NCAPOP contract.
The following expenditure was provided for NCAPOP in recent years:
- 2016/17; £16.9 million;
- 2017/18; £16.9 million;
- 2018/19; £15.8 million; and
- 2019/20; £15.6 million.
Clinical audits delivered under the NCAPOP portfolio can be found at the following link:
https://www.hqip.org.uk/a-z-of-nca/#.XAlJvcK7KUk
NCAPOP outcome review of delivered work can be found at the following link:
https://www.hqip.org.uk/clinical-outcome-review-programmes/#.XiseTmC7JPY
Asked by: James Brokenshire (Conservative - Old Bexley and Sidcup)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what priorities he has set for the National Clinical Audit and Patient Outcomes Programme (NCOPOP) for the delivery of clinical audits; and what oversight arrangements are in place to ensure those priorities are delivered effectively.
Answered by Nadine Dorries
The National Clinical Audit and Patient Outcomes Programme (NCAPOP) is made up of a number of funding streams comprising over 30 topics and aim to mirror the priority areas set out in the NHS Long Term Plan. The National Quality Board (NQB) established an NQB NCAPOP Partners Group, with representation from NHS England and NHS Improvement, the Care Quality Commission, the National Institute for Health and Care Excellence (NICE) and Health Education England, amongst others, to ensure the NCAPOP portfolio continues to support the priorities of the wider National Health Service.
NCAPOP audits are commissioned by the Healthcare Quality Improvement Partnership (HQIP) which manages the programme on behalf of NHS England and NHS Improvement. In addition, NHS England and NHS Improvement have contractual accountability meetings to review the Key Performance indicators associated with the NCAPOP contract.
The following expenditure was provided for NCAPOP in recent years:
- 2016/17; £16.9 million;
- 2017/18; £16.9 million;
- 2018/19; £15.8 million; and
- 2019/20; £15.6 million.
Clinical audits delivered under the NCAPOP portfolio can be found at the following link:
https://www.hqip.org.uk/a-z-of-nca/#.XAlJvcK7KUk
NCAPOP outcome review of delivered work can be found at the following link:
https://www.hqip.org.uk/clinical-outcome-review-programmes/#.XiseTmC7JPY
Asked by: James Brokenshire (Conservative - Old Bexley and Sidcup)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will set out the members of NHS England's Clinical Expert Group for lung cancer.
Answered by Steve Brine
The membership of the Clinical Expert Group (CEG) for Lung Cancer is listed below and publicly available on the Roy Castle Lung Cancer Foundation website. It will also be published on NHS England’s website shortly.
Lung Cancer Clinical Expert Group membership
Prof David Baldwin Respiratory Physician, East Midlands / Lung Cancer CEG Chair
Prof Sam Janes Chest Physician and Scientist, Early Detection, London / Lung Cancer CEG Vice Chair
Mrs Diana Borthwick Clinical Nurse Specialist in Lung Cancer / former Chair of National Lung Cancer Forum for Nurses
Dr Julie Hendry Respiratory Physician, Merseyside and Cheshire Cancer Network
Dr David Gilligan Clinical Oncologist, East of England
Dr Andrew Bates Clinical Oncologist, Southampton
Dr Anand Devaraj Thoracic Radiologist, London
Mrs Sue Maughn Commissioning Director-Cancer, East London Health and Care Partnership
Dr Amelia Randle General Practitioner The Park Surgery, Shepton Mallet / Clinical Lead Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance
Dr Paul Cane Consultant Histopathologist, London
Prof Denis Talbot Professor of Cancer Medicine, University of Oxford, Thames Valley Cancer Network
Dr Imran Husain Consultant Respiratory Physician, West Midlands
Dr Sanjay Popat Consultant Medical Oncologist, Royal Marsden Hospital
Dr Yvonne Summers Medical Oncologist, The Christie and University Hospital of South Manchester, Manchester
Dr Andrew Wilcock Clinical Reader in Palliative Medicine and Medical Oncology, Nottingham
Mr Martin Grange Patient Representative, Hampshire
Mrs Michele McMahon Patient Representative, Liverpool
Mrs Janette Rawlinson Patient Representative, West Midlands / European Lung Foundation Lung cancer patient advisory group / National Cancer Research Institute Clinical Studies Group (lung cancer) consumer member / British Thoracic Oncology Group steering committee member, Cancer Research UK SMP board member (patient representative) / Lay member Sandwell and West Birmingham Clinical Commissioning Group
Dr Robert Rintoul Reader in Thoracic Oncology, University of Cambridge / Honorary Consultant in Respiratory Medicine, Papworth Hospital, Cambridge
Dr Jeremy Killen Consultant in Respiratory Medicine, North of England
Dr Sion Barnard Thoracic Surgeon / Society of Cardiothoracic Surgeons
Mr Doug West Consultant Thoracic Surgeon, Bristol
Dr Neil Bayman Consultant Clinical Oncologist, Greater Manchester
Mrs Barbara Gill Programme Lead Accelerate, Coordinate, Evaluate (ACE), NHS England / Cancer Research UK
Dr Vytis Dudzevicius Consultant in Respiratory Medicine, London / Lung multidisciplinary team Lead and Lung Cancer Lead Clinician
Mrs Vanessa Beattie Clinical Nurse Specialist in Lung Cancer / National Lung Cancer Forum for Nurses Chair
Mrs Karen Clayton Macmillan Lung Cancer Lead Nurse, East Cheshire NHS Trust / National Lung Cancer Forum for Nurses
Dr Matthew Evison Consultant in Respiratory Medicine, Manchester / Director of the Lung Pathway Board for Greater Manchester Cancer
Dr Ian Woolhouse Respiratory Physician, Chair of West Midlands Lung Expert Advisory Group
The National Optimal Lung Cancer Pathway was developed with the assistance of further expert clinicians:
Dr Sadia Anwar Consultant Respiratory Physician, Nottingham
Dr Matthew Callister Consultant Respiratory Physician, Leeds
Dr Paul Beckett Consultant Respiratory Physician, Derby
Prof Mick Peake Consultant and Senior Lecturer in Respiratory Medicine / National Clinical Lead, NHS Cancer Improvement/ Clinical Lead, National Cancer Intelligence Network
Asked by: James Brokenshire (Conservative - Old Bexley and Sidcup)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will set out recent advice and guidance provided by NHS England's Clinical Expert Group on the early detection and diagnosis of lung cancer.
Answered by Steve Brine
The Clinical Expert Group for Lung Cancer published three documents in 2017/18, and also provided clinical advice for the development of a handbook to support delivery of best practice lung cancer pathways. Details of the documents and handbook are provided below.
- National Optimal Lung Cancer Pathway (2017);
- National Optimal Lung Cancer Pathway Implementation Guide (2017);
- Clinical Advice for the Provision of Lung Cancer Services (2017); and
- Handbook: Implementing a timed lung cancer diagnostic pathway (2018).